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Abstract
Background: Up to date information on poisoning trends is important. This study reports the epidemiology of all
hospitalized acute poisonings in Oslo, including mortality, follow-up referrals, and whether the introduction of
over-the-counter sales of paracetamol outside pharmacies had an impact on the frequency of poisonings.
Methods: All acute poisonings of adults (≥16 years) treated at the five hospitals in Oslo from April 2008 to April
2009 were included consecutively in an observational cross-sectional multicentre study. A standardized form was
completed by the treating physician, which covered the study aims. All deaths by poisoning in and outside
hospitals were registered at the Institute of Forensic Medicine.
Results: There were 1065 hospital admissions of 912 individuals; 460 (50%) were male, and the median age was
36 years. The annual incidence was 2.0 per 1000. The most frequent toxic agents were ethanol (18%),
benzodiazepines (15%), paracetamol (11%), and opioids (11%). Physicians classified 46% as possible or definite
suicide attempts, 37% as accidental overdoses with substances of abuse (AOSA), and 16% as other accidents.
Twenty-four per cent were discharged without any follow-up and the no follow-up odds were highest for AOSA.
There were 117 deaths (eight in hospital), of which 75% were males, and the median age was 41 years. Thus, the
annual mortality rate was 25 per 100 000 and the in-hospital mortality was 0.8%. Opioids were the most frequent
cause of death.
Conclusions: The incidence of hospitalized acute poisonings in Oslo was similar to that in 2003 and there was an
equal sex distribution. Compared with a study performed in Oslo in 2003, there has been an increase in poisonings
with a suicidal intention. The in-hospital mortality was low and nine out of ten deaths occurred outside hospitals.
Opioids were the leading cause of death, so preventive measures should be encouraged among substance abusers.
The number of poisonings caused by paracetamol remained unchanged after the introduction of over-the-counter
sales outside pharmacies and there were no deaths, so over-the-counter sales may be considered safe.
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Background
Acute poisoning is a common cause of hospital
admissions worldwide [1]. The validity of retrospect-
ive registry data has been questioned and prospective
studies or prospective database registrations are the
preferred sources of information [2]. In Oslo, studies
of acute poisoning throughout the whole city were
performed during 1980 and 2003 [3,4]. The study
protocols were similar in both studies where the
whole city was monitored over the entire year. Thus,
Oslo could provide a reference for such studies and
research based on the same protocol is in progress
in Yekaterinburg (Russia), Estonia, and Baku (Azer-
baijan). The gap between national figures (e.g., the
European Monitoring Centre for Drugs and Drug
Addiction, EMCDDA) and the picture seen by spe-
cialist health care providers is substantial [3,5]. Thus,
there is a time lag between the introduction of new
substances of abuse and the diagnostics, treatment,
prevention, and final legal action required to deal
with them.
The in-hospital mortality after a poisoning episode
has fallen to 1–2% [4,6], which is most probably due to
improved pre-hospital care and hospital intensive care
treatment. Therefore, the focus has shifted towards pre-
venting repetition and improving aftercare. One in
three patients experiences repeated poisoning within a
year and an increased mortality rate has been found
even 20 years after a self-poisoning episode [7,8], which
emphasizes the importance of adequate follow-up. Fur-
thermore, paracetamol (10 g) was released for around-
the-clock over-the-counter (OTC) sales outside of
pharmacies in November 2003 (late in the second
study). OTC packages accounted for 58% of the total
number of doses of paracetamol in 2008 [9]. The rela-
tionship between drug availability and suicide attempts
is recognized, which made this decision controversial
[10]. In 2003, the proportion of paracetamol poisonings
in Oslo was 12% (n = 116) [3].
Updated information on poisoning trends and mortal-
ity is valuable for clinicians and for establishing pre-
ventative initiatives. Most deaths caused by poisoning
occur outside hospitals, so including these deaths is im-
portant when determining the total mortality. Identifying
factors associated with follow-ups may identify targets
for improved aftercare. Furthermore, any increase in
paracetamol poisonings may result in a re-evaluation of
OTC sales.
Our main objectives were as follows: 1) to provide an
up to date account of the incidence of hospitalized acute
poisonings in Oslo; 2) to document the poisoning pat-
tern and suicide attempts of hospitalized patients, based
on age and sex; 3) to study follow-up referrals depending
on the reason underlying the poisoning; 4) to calculate
the mortality inside and outside hospital; and 5) to de-
termine whether the incidence of paracetamol poison-
ings increased after the introduction of OTC sales
outside pharmacies.
Methods
Study design
This study was part of a larger observational cross-
sectional multicentre study conducted from April 15th
2008 to April 14th 2009 at the Emergency Medical
Agency (EMA, “Oslo Legevakt”, the outpatient emer-
gency clinic in Oslo), the five hospitals that treat poi-
soned patients in Oslo, and the Institute of Forensic
Medicine in the University of Oslo. As Akershus Univer-
sity Hospital is located just outside Oslo and mainly
treats patients from outside Oslo, the latter patient
group was excluded. This article presents epidemio-
logical data from the hospitals and the Institute of Fo-
rensic Medicine. Clinical data derived from the EMA
and hospital treatments are presented separately [11,12].
This study had a similar design to another study con-
ducted during 2003. Oslo is the capital of Norway and
the population was 568,809 in July 2008, with 466,423
aged ≥16 years. All the hospitals in Oslo belong to the
National Public Health Care service. Poisoned patients
are not treated in other clinics (e.g., private) than the
EMA and the five hospitals.
Inclusion criteria
All adults (≥16 years) presenting with a primary diagno-
sis of acute poisoning were included consecutively from
the five hospitals. Poisoning was defined as exposure to
a substance in toxic amounts. Chronic poisonings were
not included. In cases where poisoning was a secondary
diagnosis, poisoning itself had to warrant admission. In
cases where ethanol and trauma were co-diagnoses, or
in doubt, a blood alcohol concentration of 54 mmol/L
(250 mg/dL) was used as cut-off. Participation was based
on informed verbal consent. Data on deaths occurring in
and outside hospitals in Oslo were obtained from the In-
stitute of Forensic Medicine, which is legally obliged to
examine all deaths due to poisoning. Permanent resi-
dency outside Oslo was not an exclusion criterion in the
hospitals located in Oslo. An extensive laboratory screen
was performed at the Institute of Forensic Medicine.
Drug analyses were performed for hospitalized patients
according to the diagnostic needs determined by the
treating physician.
Data collection
Evaluations were conducted by all treating physicians at
the five hospitals with the completion of a standardized
form that covered the study objectives. Each hospital
had a coordinator (MD) who monitored the study and
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manually cross-checked forms against electronic patient
lists to ensure that all patients meeting the criteria were
included. In the few cases where patients had been over-
looked, a form was completed based on each patient’s
electronic medical record. This journal was also used as
a supplement when variables were missing. Missing vari-
ables were coded as unknown and excluded from that
particular analysis.
The data were entered manually into an SPSS spread-
sheet and checked systematically. Ten per cent of the
variables were cross-checked randomly with the original
forms, indicating 99.94% consistency.
Outcome measures
In cases where patients were exposed to more than one
substance, the substance suspected to be present in the
most toxic amount was assumed to be the main agent.
This was based on the treating physician’s clinical evalu-
ation of all available information, such as statements
from patients, companions, outpatient clinics, ambu-
lance services, clinical observations, laboratory findings,
or findings at the scene. Substances suspected to be less
toxic were registered as co-agents. Carbon monoxide
(CO) poisonings were classified as either CO/engine
smoke or CO/fire smoke poisonings. Drug screening
was performed in all medico-legal autopsies and the
main toxic agents were determined by a forensic path-
ologist. Follow-ups were registered as a categorical vari-
able and transfer to a psychiatric ward was considered
the highest level of referral.
The cause of poisoning was evaluated by the treating
physician. Poisonings due to substance abuse, such as
heroin and ethanol taken for intoxication purposes, were
defined as accidental overdoses with substances of abuse
(AOSA). Becks’ suicidal intent scale (SIS) was completed
if a suicide attempt was suspected. The SIS is a 15-
question form used to evaluate the severity of suicidal
intention [13]. Each question is scored 0–2, resulting in
a final score ranging from 0 to 30. A suicidal intent in
poisoning was classified as either a possible or definite
suicide attempt. This distinction was based on whether
the patient had taken a toxic agent they considered le-
thal and whether other measures had been taken to en-
sure a lethal outcome. If the patient reported an
ambivalent motive, e.g., by seeking help shortly after in-
gestion, the motive was considered a possible suicide at-
tempt. Accidents included external causes of poisoning
and self-inflicted accidents (e.g., taking the wrong medi-
cation) where the agent was not used for self-harm or
intoxication purposes. At the Institute of Forensic Medi-
cine, the intention was classified as an open verdict
where the intention was unknown. The intention cat-
egories differed slightly from the four used in 2003,
i.e., definite or possible suicide attempt, appeal for help,
and accident/intoxication. Moreover, the SIS was not
used in 2003.
Statistics
Pearson’s chi-square or Fisher’s exact test (cell values <5)
were used to compare frequencies. Age comparisons
were performed using the Mann–Whitney U test.
Univariate logistic regression was used to analyse the
association between poisoning intention and the seven
major referral end-points: transfer to psychiatric wards,
psychiatric outpatient treatment, drug addiction clinics,
general practitioners, other follow-up (including transfer
to other hospitals, emergency social services, the Norwe-
gian Directorate for Children, Youth and Family Affairs,
and other specialists), no referral, and those leaving
against medical advice. Subjects who died in hospital or
who had unknown intention were excluded from this
particular analysis. Findings with p-values <0.05 were
considered statistically significant. SPSS 16.0 (SPSS Inc.,
Chicago, IL, USA) was used to analyse the data.
Ethics
This study was approved by the Norwegian Regional
Ethics Committee and the National Data Inspectorate.
Studying intoxicated patients is challenging due to the
nature of their medical condition, such as the acquisition
of written consent. Study subjects were informed about
the aims of the study and they were given an informa-
tion leaflet containing the name and phone number of
the study coordinator. They were also given the right to
refuse to participate in the study or withdraw consent to
participate at any time without reprisal. Their verbal
consent was confirmed by the independent interviewing
physician.
Results
Of the 1088 hospitalized patients meeting the inclusion
criteria, 23 (2.1%) refused participation. Non-participating
patients did not differ significantly from the study pop-
ulation in terms of age, sex, intention, and main toxic
agents.
The 1065 hospitalized admissions comprised 912 indi-
viduals (Figure 1). Of these admissions, 919 (86%) had
permanent residence in Oslo, giving an annual incidence
of 2.0 per 1000 inhabitants for both sexes (2.3 per 1000
if all patients were included). The incidence varied in
the different age groups, with a peak incidence of 3.1
and 3.5 in males and females aged 20–29, respectively,
declining with age (Figure 2). Of the subjects, 460 (50%)
were males and the median age was 36 years (range
16–93), i.e., 37 for males and 34 for females (ns). The
number of hospital contacts varied, with 822 (90%) being
admitted once, 60 (7%) twice, while 30 (3%) were admit-
ted 3–10 times.
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The most frequent main toxic agents were ethanol
(n = 194, 18%), benzodiazepines (n = 160, 15%), para-
cetamol (n = 116, 11%) and opioids (n = 114, 11%)
(Table 1). Ethanol, opioids, GHB, and amphetamine were
significantly more common in males, whereas paraceta-
mol, anti-depressants, and neuroleptics were significantly
more common in females. Multiple agents were taken
by 593 (56%) and the most common combination was
benzodiazepines and ethanol (n = 80, 8%). The most
common co-agents were ethanol (n = 251, 24%), benzo-
diazepines (n = 133, 12%), and benzodiazepine derivates
(n = 70, 7%). The toxic agent reflected different
EMA 
n=337 (32%) 
Oslo Hospitals 
n = 1065* (100%) 
Ambulance
n=588 (55%)
Other
doctor
n=56 (5%)
Directly/
relatives 
n=24 (2%) 
Mode of presentation   
Referred to follow-up   
n = 692 (65%)
Other 
n=41 (4%) 
Psychiatric
ward
n=19 (2%) 
Psychiatric  
Outpatient 
n=186 (17%)
Psychiatric
Ward
n=211 (20%)
Other 
n=75 (7%)
G.P. 
n=125 (12%)
Addiction 
Clinic 
n=41 (4%)
No follow-up
n=251 (24%) 
Left against 
medical advice 
n=114 (11%)
Other 
hospital 
n=54 (5%) 
Deaths 
n= 8 (0.8%) 
Deaths in Oslo 
n=117 (100%)
Deaths outside 
hospital 
n=109
Deaths 
n = 117 (100%)
Figure 1 Patient flow in 1065 hospital admissions for acute poisoning in Oslo in 2008. *Excludes 23 subjects who refused to participate.
†81 transferred under paragraph of compulsory observation. GP: general practitioner; EMA: the Emergency Medical Agency (outpatient clinic).
Other presentation includes the police and other institutions. Other referral was mainly the emergency social services.
Figure 2 Incidence according to age and sex in 1065 hospital admissions for acute poisoning in Oslo in 2008. *Significant difference.
Lund et al. BMC Public Health 2012, 12:858 Page 4 of 10
http://www.biomedcentral.com/1471-2458/12/858
intentions. The proportion of possible or definite suicide
attempts was highest with paracetamol (n = 101, 87%)
and benzodiazepines (n = 102, 64%).
The classification of toxic agent(s) by hospitals was
based on statements from patients (n = 759, 71%), la-
boratory findings (n = 529, 50%), ambulance service or
outpatient clinics (n = 387, 36%), companions (n = 275,
26%), clinical observations (n = 205, 19%), or findings at
the scene (n = 20, 2%). This variable was missing from
seven (1%) forms. The diagnosis was not based on la-
boratory results alone. However, the diagnosis was based
solely on statements from the patient in 203 (19%) cases.
The source of prescription drugs was missing in 349
(30%) cases (Table 2). Paracetamol (non-codeine com-
bination) was purchased OTC in 75 cases (82%) and with a
prescription in nine cases (10%). Anti-depressants and
neuroleptics were obtained mainly from physicians and
more often from general practitioners than psychiatrists.
Benzodiazepines were bought illegally in 54 (30%) cases.
Possible or definite suicide attempts accounted for 495
(46%) admissions (Table 3). The SIS score was used in
349 (71%) of these cases and the median score was 8.0
(interquartile range (IQR) 5–11) for possible and 17.5
(IQR 13–21) for definite suicide attempts. AOSA ac-
counted for 399 (37%) admissions and 170 (16%) were
other accidents, of which 99 (58%) were self-inflicted.
One patient lacked a recorded intention. There were
significantly more records of AOSA in males, whereas
possible and definite suicide attempts were more com-
mon in females. However, there were no significant
sex differences in the SIS scores of subjects with defin-
ite or possible suicide attempts. Patients with other ac-
cidental poisonings were significantly older than the
remainder (difference in the mean 6.2 years, p < 0.001).
Table 1 Total admissions based on agent, and the main agents separated by sex in 1065 hospital admissions for acute
poisoning in Oslo in 2008
Toxic agent Main + co-agents Main agents
n (%) Total n (%) Males n (%) Females n (%) p-value
Ethanol 445 (42) 194 (18) 120 (22) 74 (14) <0.001*
BZD 293 (28) 160 (15) 73 (14) 87 (16) ns
Paracetamol2 184 (17) 116 (11) 31 (6) 85 (16) <0.001*
Opioids 152 (14) 114 (11) 80 (15) 34 (6) <0.001*
GHB 96 (9) 85 (8) 67 (13) 18 (3) <0.001*
Neuroleptics 99 (9) 60 (6) 15 (3) 45 (9) <0.001*
Anti-depressants 106 (10) 59 (6) 16 (3) 43 (8) <0.001*
BZD derivates 128 (12) 58 (5) 24 (4) 34 (6) ns
CO and fire smoke 50 (5) 48 (5) 31 (6) 17 (3) ns
Amphetamine 66 (6) 25 (2) 21 (4) 4 (1) <0.001*
Cardiovascular 27 (3) 18 (2) 8 (1) 10 (2) ns
Anti-epileptics 48 (5) 17 (2) 5 (1) 12 (2) ns
Cocaine 30 (3) 13 (1) 10 (2) 3 (1) ns
NSAIDs 54 (5) 10 (1) 3 (1) 7 (1) ns
Other gases 13 (1) 11 (1) 4 (1) 7 (1) ns
Carisoprodol1 14 (1) 8 (1) 3 (1) 5 (1) ns
Scopolamine 9 (1) 8 (1) 4 (1) 4 (1) ns
Anti-coagulants 8 (1) 7 (1) 3 (1) 4 (1) ns
Lithium 5 (<0.5) 5 (<0.5) 1 (<0.5) 4 (1) ns
Antihistamines 54 (5) 4 (<0.5) 0 (0) 4 (1) ns
Insulin 4 (<0.5) 4 (<0.5) 2 (<0.5) 2 (<0.5) ns
Other 139 (13) 41 (4) 15 (3) 26 (5) ns
Total 1065 (100) 536 (100) 529 (100)
*Significant.
1Carisoprodol was taken off the market May 1st 2007.
2A codeine–paracetamol combination drug was the main agent in 29 cases.
Main agents present in ≤3 admissions were defined as “other”. In six cases, the main agent was unknown.
BZD vbenzodiazepines, GHB gamma-hydroxybutyric acid, NSAIDs non-steroidal anti-inflammatory drugs.
Of the opioids that were main agent, 79 were illegal substances. Of the legal opioids, 14 were methadone and none were buprenorphine. Of the anti-depressants
as the main agent, 34 were selective serotonin reuptake inhibitors and 13 were tricycle anti-depressants.
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There were no other age differences among the intention
categories.
Sixty-five per cent (n = 692) were referred for follow-
ups, 24% (n = 251) were discharged without referral, and
11% (n = 114) left against medical advice (Figure 1). Sui-
cide attempt subjects were mainly transferred to psychi-
atric wards (n = 187, 38%) or referred to psychiatric
outpatient clinics (n = 142, 29%) (Table 4). Compared
with the suicide attempt subjects, patients with AOSA
or other accidental poisonings were more likely to be
discharged without follow-up, i.e., OR = 13 (CI 8–
20) and OR = 11 (CI 7–18), respectively. Further-
more, patients with AOSA were more likely to leave
against medical advice (OR = 4, CI 3–7). Twenty-
five (5%) patients with a definite or possible suicidal
intention were discharged without any follow-up.
None were reported as dead one month after
discharge.
There were 117 deaths from acute poisoning in Oslo
during the study year (Table 5). Of these, 101 (86%) were
Oslo residents, giving an annual mortality rate of 25 per
100 000. Eighty–eight (75%) were males and the median
age was 41 years (range 18–86), i.e., 41 (range 18–77)
for males and 50 (range 19–86) for females (p = 0.02).
Eight patients (0.8%) died during their hospital stay.
Six (75%) were females and the median age was 42 years
(range 25–86), i.e., 35 for males and 57 for females (ns).
The three definite suicides were caused by insulin, CO/
fire smoke, and the calcium antagonist amlodipine. The
accidental poisoning was caused by benzodiazepines in
an elderly patient with dementia.
There were 109 deaths outside hospitals, of which 69
(63%) were found at home, 13 (12%) in a public area,
eight (7%) in an institution, and 19 (17%) in other places
(e.g., hotel room or a friend’s house). Eighty-six (79%)
were males, and the median age was 41 years (range 18–
77), i.e., 41 for males and 50 for females (ns). There were
significantly more male deaths outside hospital (p =
0.002) and the population was younger than those who
died in hospital (p = 0.026). Sixty-seven (61%) of the
deaths were evaluated as AOSA and 49 (73%) of these
were caused by opioids.
Paracetamol was considered as the main agent in 116
(11%) hospital admissions, including 29 poisonings with
Table 2 Source of prescription drugs in 801 cases of acute poisoning in Oslo in 2008
G.P.
n (%)
Psych.
n (%)
Other doc
n (%)
OTC
n (%)
Friend/family
n (%)
Bought illegally
n (%)
Total
n (%)
Missing
n
BZD 90 (50) 12 (7) 1 (<0.5) 2 (1) 21 (12) 54 (30) 180 (100) 113
Paracetamol 8 (9) 0 (0) 1 (1) 75 (82) 7 (8) 0 (0) 91 (100) 23
Codeine + paracetamol* 24 (56) 0 (0) 7 (16) 2 (5) 9 (21) 1 (2) 43 (100) 27
Anti-depressants 53 (65) 23 (28) 0 (0) 0 (0) 6 (7) 0 (0) 82 (100) 24
BZD derivates 52 (67) 8 (10) 7 (9) 0 (0) 8 (10) 3 (4) 78 (100) 50
Neuroleptics 41 (55) 31 (42) 1 (1) 0 (0) 0 (0) 1 (1) 74 (100) 25
Legal opioids 16 (39) 0 (0) 1 (2) 0 (0) 4 (10) 20 (49) 41 (100) 16
Anti-epileptics 19 (53) 11 (31) 2 (6) 0 (0) 2 (6) 2 (6) 36 (100) 12
Antihistamines 22 (69) 5 (16) 1 (3) 1 (3) 3(9) 0 (0) 32 (100) 22
Cardiovascular 17 (74) 0 (0) 1 (4) 0 (0) 5 (22) 0 (0) 23 (100) 4
Other 47 (39) 6 (5) 9 (7) 31 (26) 20 (17) 8 (7) 121 (100) 33
Total 389 (49) 96 (12) 31 (4) 111 (14) 85 (11) 89 (11) 801 (100) 349
BZD benzodiazepines, Doc, doctors, G.P., general practitioner, OTC over-the-counter, Psych, psychiatrist.
*Combination drug requiring prescription.
No patient reported that they obtained the drug from multiple doctors.
Table 3 Physician evaluations of intention in 1065 hospital admissions for acute poisoning in Oslo in 2008
Intention Males n (%) Females n (%) 95 % CI Total n (%)
AOSA 278 (52) 121 (23) <0.001* 399 (37)
Possible suicide attempt 115 (21) 229 (43) <0.001* 344 (32)
Other accidents 87 (16) 83 (16) ns 170 (16)
Definite suicide attempt 56 (10) 95 (18) <0.001* 151 (14)
Unknown 0 (0) 1 (<0.5) ns 1 (<0.5)
Total 536 (100) 529 (100) 1065 (100)
*Significant.
AOSA accidental overdoses with substances of abuse, CI Confidence interval.
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a codeine–paracetamol combination drug, and it was
present in 184 (17%) cases (Table 1). No patient with
paracetamol poisoning developed liver damage or other
sequelae. No patients died of paracetamol poisoning, but
six died of poisoning with a codeine–paracetamol com-
bination drug.
Discussion
Main summary of results
The incidence of hospitalized acute poisoning in Oslo
was 2.0 per 1000, with an equal sex distribution. Almost
half of the patients had a suicidal intention. A quarter of
the patients were discharged without plans for follow-
up, mainly because they were AOSA. The in-hospital
mortality was 0.8%. Nine out of ten deaths occurred out-
side hospitals and opioids were the leading cause of
death by poisoning. The number of hospitalized para-
cetamol poisonings remained unchanged after the intro-
duction of OTC sales outside pharmacies, with no
complications or deaths.
Incidence
Data describing an unselected population of acute poison-
ings and deaths are sparse, making comparisons difficult.
The incidence of hospitalized acute poisonings in Oslo
was similar to that in 2003 [3], but marginally lower than
the only large prospective study conducted in Europe,
which was the Spanish VEIA 2004 study (2.3 per 1000)
[14]. In contrast to Spain and most other countries, a sep-
arate emergency outpatient clinic (EMA) in Oslo treats
the majority of substance abuse poisonings that would
otherwise be present in hospital emergency departments
(e.g., ethanol, opioid, and stimulants). Twice the number
of patients (n = 2348) were treated at the EMA in 2008
compared with all Oslo hospitals, making the total inci-
dence of acute poisonings in Oslo higher [11].
Both sexes were equally represented in our study,
which contrasts with the female predominance that is
often observed [14] and the male predominance among
those treated only in a pre-hospital setting [15].
Toxic agents
Ethanol and benzodiazepines were the main agents
taken, as found in the Spanish VEIA study [14].
Table 4 Odds for different follow-ups according to intention in 1002 hospital admissions for acute poisoning in Oslo in
2008. Results of univariate logistic regression
Intention Psych.ward Psych. OPC Add. clinic G.P. Other No referral Left
Suicide attempt Reference 38 % 29 % 4 % 9 % 10 % 5 %† 5 %
AOSA OR (95 % CI) 4 % 0.06*
(0.04–0.11)
8 % 0.21*
(0.14–0.32)
5 % 1.39
(0.74–2.63)
12 % 1.37
(0.89–2.10)
11 % 1.13
(0.73–1.73)
41 % 13.04*
(8.32–20.44)
19 % 4.47*
(2.76–7.24)
Other accidents
OR (95 % CI)
5 % 0.09*
(0.05–0.18)
8 % 0.21*
(0.11–0.37)
1 % 0.15
(0.02–1.11)
19 % 2.32*
(1.42–3.79)
21 % 2.44**
(1.52–3.91)
37 % 11.08*
(6.66–18.43)
9 % 1.90
(0.97–3.71)
Total 20 % 18 % 4 % 12 % 12 % 24 % 11 %
*Significant, p < 0.001, **Significant, p < 0.05.
†Two definite suicide attempts.
AOSA accidental overdoses with substances of abuse, CI confidence interval, G.P. general practitioner, Psych. OPC psychiatric outpatient clinic.
Both AOSA and other accidents were compared with suicide attempts. The eight patients who died, one patient with unknown intention, and 54 patients
transferred to a different hospital were excluded from this analysis.
Table 5 Intention and main agents causing deaths from
poisoning inside and outside hospitals in Oslo
Hospital
n (%)
Outside
n (%)
Total
n (%)
Age (years) Median 42 41 41
IQR 26–77 29–51 29–51
Sex Males 2 (25) 86 (79) 88 (75)
Females 6 (75) 23 (21) 29 (25)
Intention AOSA 3 (38) 67 (62) 70 (58)
Other accidents 1 (13) 20 (18) 21 (21)
Definite suicide 3 (38) 9 (8) 12 (10)
Possible suicide 1 (13) 9 (8) 10 (9)
Open verdict 0 (0) 4 (4) 4 (3)
Main agent Opioids 4 (50) 68 (62) 72 (62)
CO 1 (13) 10 (9) 11 (9)
Ethanol 0 (0) 7 (6) 7 (6)
Codeine
(+ paracetamol)*
0 (0) 6 (6) 6 (5)
Cardiovascular drugs 1 (13) 1 (1) 2 (2)
Benzodiazepines 1 (13) 3 (3) 4 (3)
Other illegal 0 (0) 3 (3) 3 (3)
Anti-depressants 0 (0) 3 (3) 3 (3)
Anti-epileptics 0 (0) 3 (3) 3 (3)
Other 1 (13) 5 (5) 6 (5)
Co-agent(s) Yes 5 (63) 93 (85) 98 (84)
No 3 (38) 16 (15) 19 (16)
Total 8 (100) 109 (100) 117 (100)
AOSA accidental overdoses with substances of abuse, IQR interquartile range.
*Combination drug Of the deaths by opioids, nine were due to methadone.
The patient who died of benzodiazepines in hospital was 75-years-old, while
the three patients who died outside hospital had taken multiple toxic agents.
Of the deaths by CO, one was caused by car engine smoke, while the
remainder were caused by fire smoke. The death in hospital by “other” was
caused by insulin.
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Compared with Oslo in 2003, the proportion of opioids
(11% vs. 7%, p = 0.005) and CO/fire smoke (4% vs. 1%, p
< 0.001) had increased significantly. However, this obser-
vation did not agree with EMCDDA or the United
Nations Office on Drugs and Crime (UNODC) reports,
which both report estimated declines in the amounts of
heroin seizures and opiate use [16,17]. This demonstrates
that national figures do not always reflect the local clin-
ical reality. Tricyclic antidepressants (TCA) still contrib-
uted to a third of the poisonings by anti-depressants,
which agreed with the stable prescription rates over the
last five years [9,18]. As often observed, males had more
poisonings with substances of abuse, while females had
more poisonings with pharmaceuticals such as paraceta-
mol, neuroleptics and antidepressants. However, females
did not have more poisonings with benzodiazepines. Sur-
prisingly few patients had taken multiple agents [3].
Half of the prescription drugs were obtained from the
patient’s general practitioner, illustrating their potential
role in the prevention of acute poisonings. Compared
with 1980, more patients had obtained the toxic agent
from their general practitioner (49% vs. 36%), whereas
fewer were supplied by their family or friends (11% vs.
33%) [19]. Furthermore, none reported that they
obtained the agent from multiple doctors, which was the
case with 3% of the admissions in 1980. An increased
focus on prescription practices, the introduction of a
general practitioner scheme in 2001, and the establish-
ment of a central national registry for the prescription of
potential drugs of abuse in 2003 have apparently been
effective in this respect.
Suicidal intentions
The observed sex difference in intention was reflected
by the toxic agents taken and it may be because males
use other more violent and lethal suicide methods to a
greater extent [20]. Poisonings with a suicidal intention
had increased compared with the 2003 study (14% defin-
ite and 32% possible, vs. 10% definite and 25% possible
suicide attempts) [3], which was most evident in females.
This was supported by statistics from Norway reporting
a 23% increase in completed suicides among women
from 2003 to 2008, mainly by poisoning, strangulation,
and drowning [21]. The same tendency was not seen
among men.
Follow-ups
The proportion of patients referred to follow-ups after a
poisoning episode was lower compared with 2003 (75%
vs. 82%, p < 0.001) [3]. One positive finding was that few
patients with a suicidal intention were discharged with-
out follow-up, in accordance with current guidelines.
This is important because a previous suicide attempt is
the strongest known predictor of completing suicide
[22]. However, a quarter of patients who repeatedly poi-
soned themselves during the 2003-study changed their
poisoning intention from suicide attempts to uninten-
tional drug-abuse-related overdoses or vice versa [8], il-
lustrating co-morbidity between substance abuse and
suicidal behaviour. The high proportion of substance
abusers discharged without follow-up is concerning
given the high mortality rate by poisoning and other
causes even 20 years after a poisoning episode, irrespect-
ive of the intention behind the poisoning [7]. Motivation
may be a challenge, but there are follow-up alternatives
for overdose victims without suicidal intent in Oslo. Al-
though more follow-ups should be encouraged, the
effects on repetition and mortality are incompletely
studied.
Mortality
Both the annual total mortality and the in-hospital mor-
tality rate of acute poisoning were similar to 2003 [23].
A Turkish study reported a similar in-hospital mortality
rate of 2.2% [24]. However, as low acuity poisonings
were treated at the EMA in Oslo with zero mortality,
the in-hospital mortality rate was actually lower [11].
The deaths in and outside hospital were two distinct-
ively different groups. Accidental poisonings of elderly
women predominated in hospitals, while AOSA by opi-
ates predominated in middle-aged males outside hospi-
tals. The main cause of death by poisoning in Oslo was
opioids taken at home. According to the EMCDDA,
Norway is the European country with the most deaths
caused by the intravenous use of narcotics per inhabitant
[25]. Our finding supports this and highlights a need for
prevention initiatives. However, we do not know whether
the patients attended their designated follow-up appoint-
ments. Moreover, the high proportion of opioid users
that left the hospital against medical advice remains a
challenge. We will address these aspects in a further
study. Pilot naloxone distribution programmes in the US
have reported promising results [26], so this may be an
important tool for mortality prevention.
Paracetamol
OTC paracetamol accounted for 82% of the acute poi-
sonings with paracetamol, but only 58% of the total
doses sold in Norway in 2008 [9]. This may indicate a
correlation between drug availability and self-harm.
However, the incidence of hospitalized paracetamol poi-
sonings in Oslo did not change significantly, although
the total paracetamol sales in Norway increased by 26%
after the introduction of OTC sales outside pharmacies
[9,18]. None developed hepatic failure and there were no
fatalities. The six deaths linked to paracetamol were
caused by a codeine combination drug that required a
prescription. Thus, we have no evidence that OTC sales
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are unsafe when restricted to a package size of 10 g. Our
findings support a Canadian study, where the introduc-
tion of OTC analgesics in six provinces had no impact
on hospital admission [27]. However, paracetamol has
been freely available for decades in Australia and studies
have reported an increase in overdoses over recent years
[28]. Although the case-fatality ratio for paracetamol is
low, its widespread use places it among the leading
causes of fulminant hepatic failure and drug-related fa-
talities in both the US and UK [29]. OTC sales are there-
fore controversial, although there is limited evidence
supporting a restriction. In the US, the elimination of
prescription paracetamol/opioid combination products
is under discussion [30].
Strengths and limitations
A major strength of this study is that it is prospective,
performed within a defined geographical area (capital),
and it includes unselected material on all acute poison-
ings throughout a whole year. Similar studies were per-
formed in the same area during 1980 and 2003, which
makes these comparisons more reliable than comparing
retrospective studies from different locations.
In terms of limitations, many physicians assisted in
the inclusion of patients. This was an advantage when
ensuring complete inclusion, but it may have resulted
in high interrater variability. A few patients may also
have been missed, despite consecutive inclusion, cross-
checking of forms against hospital patient lists, and
thorough follow-ups.
It is debatable whether a more thorough verification of
toxic agents should have been performed. Treatment is
mainly symptomatic and not based on the laboratory de-
tection of toxic agents, so this study was based on clin-
ical findings and blood/urine tests used in a routine
clinical setting. Furthermore, the limited value of labora-
tory results in the clinical setting has been demonstrated
[31,32]. S-ethanol and s-paracetamol were analysed rou-
tinely where they were suspected.
The term “appeal” that was used in the 2003 study was
omitted from the present study, because it is both out-
dated and unspecific. However, this was a limitation in
the comparison of suicidal intentions among the hospita-
lized patients. Furthermore, post-mortem determination
of intention is challenging and some suicides might have
been classified as accidental deaths and vice versa.
The comparison of paracetamol poisonings with the
2003 study was not optimal because the legislation
related to OTC sales was enacted four months before
the previous study was completed. However, it took
months before the practice was implemented so this
comparison may be considered reasonable. Moreover,
adolescents <16 years of age were not included in the
present study. This may have limited the evaluation of
OTC paracetamol sales, as young adolescents are known
to have high rates of attempted suicide, potentially with
OTC drugs. It was not possible to differentiate between
paracetamol bought in and outside pharmacies.
Conclusions
The annual incidence of hospitalized acute poisonings
was 2.0 per 1000 for both sexes, which was not signifi-
cantly different from 2003. Ethanol and benzodiazepines
remained the leading causes of poisoning. The in-
hospital mortality remained low and nine out of ten
deaths occurred outside hospitals. In total, 46% of the
patients had a suicidal intention. Four out of ten patients
admitted with an accidental overdose due to substance
abuse were discharged without follow-up, which is prob-
ably too high given that opioids were the leading cause
of death by poisoning. The introduction of OTC sales of
paracetamol in packages of 10 g outside pharmacies did
not increase the paracetamol-associated poisoning rate
or mortality.
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